Incontinence, Overactive Bladder

Mar 15, 2010 Issue
Stress Incontinence [Clinical Evidence Handbook]

What are the effects of surgical and nonsurgical treatments for women with stress incontinence?

May 1, 2007 Issue
Nonpharmacologic vs. Anticholinergic Therapies for Overactive Bladder [Cochrane for Clinicians]

Anticholinergic medications are more effective than bladder training in reducing the number of voids per day. Combining an anti-cholinergic medication with bladder training is more effective than either therapy alone.

Dec 15, 2006 Issue
Newer Agents for the Management of Overactive Bladder [Article]

The anticholinergics tolterodine and oxybutynin are well established in the management of overactive bladder. However, their activity at muscarinic receptors distant from the target site (i.e., bladder) produces anticholinergic side effects leading to poor tolerability. In 2004, trospium, solifenaci...

Jan 1, 2006 Issue
Anticholinergic Drugs for Overactive Bladder [Cochrane for Clinicians]

Tolterodine (Detrol) is as effective as immediate-release oxybutynin (Ditropan) and causes less dry mouth. A dose of 1 mg tolterodine twice daily is as effective as higher dosages of tolterodine. Extended-release preparations have less risk of dry mouth but are more expensive.

Jul 1, 2005 Issue
ACOG Guidelines on Urinary Incontinence in Women [Practice Guidelines]

Recommendations on the diagnosis and treatment of urinary incontinence in women have been released by the American College of Obstetricians and Gynecologists (ACOG).

Jan 15, 2005 Issue
Selecting Medications for the Treatment of Urinary Incontinence [Article]

In response to the growing population of older patients with incontinence, pharmaceutical companies are developing new drugs to treat the condition. Before prescribing medications for incontinence, however, physicians should determine the nature and cause of the patient's incontinence. The evaluatio...

Dec 15, 2004 Issue
Transdermal Oxybutynin (Oxytrol) for Urinary Incontinence [STEPS]

The transdermal patch of oxybutynin is no more effective than the short- or long-acting oral form. The patch costs more, but causes less dry mouth. Skin reactions will cause about 10 percent of patients to stop using it.

Dec 1, 2000 Issue
Urinary Incontinence in Women: Evaluation and Management [Article]

Because the prevalence of urinary incontinence increases with age, a working knowledge of the diagnosis and treatment of the various types of urinary incontinence is fundamental to the care of women. As the population of the United States ages, primary care physicians can expect to see an increasing...

Jun 1, 1998 Issue
Diagnostic Evaluation of Urinary Incontinence in Geriatric Patients [Article]

In most cases, the evaluation of urinary incontinence requires only a history, a physical examination, urinalysis and measurement of postvoid residual urine volume. The initial purposes of the evaluation are to identify conditions requiring referral or specialized work-up and to detect and treat rev...

Pages: Previous 1 2

Email Alerts

Don't miss a single issue. Sign up for the free AFP email table of contents.

Sign Up Now